|
Interview
The great thing!
"The Brazilian unit has always been a reference when it comes to creativity and innovation"
Marlon Bastos is widely experienced in health industry and has already worked for companies like AstraZeneca, Pfizer and Abbott/Solvay. With MBA in Business Management from Fundação Dom Cabral and post-graduation in Corporate Communication from Fundação Getúlio Vargas, he is currently the Marketing director of the Brazilian unit at Zambon.
During an interview to Top Team, the executive gives details about the action taken by the city´s subway system, Metrô de São Paulo, talks about innovation and tells us why the head office has an eye on the Brazilian unit.
Check below the main parts of this interview:
Zambon has recently taken an action at Metrô de São Paulo, which had "smoke curtains". What was the aim of such action?
Such action aimed to introduce to the audience, in a different way, the Fluimicil, a medicine that is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions. At the subway station we used "smoke curtains", which caused a great visual impact as people passed through it and could notice all the benefits of breathing better.
Which technology was used at the subway station?
We used Fogscreen, a Finnish technology that produces a kind of fog. The action was taken at the 4-yellow line of the subway system of São Paulo, between June and July.
Did you have to request any special authorization from Anvisa?
Fluimicil is an OTC drug. As a consequence, we have more flexibility to promote such product, but we have always to remind our patients that if the symptoms persist they should consult a doctor.
Has this action been taken somewhere abroad?
No, Brazil was the first country to take this initiative. The idea came up when we sent our briefing to the advertising agency and it was widely discussed. The head office really enjoyed this action and decided to model it in other countries.
To wrap up, does such initiative put the Brazilian unit in the limelight worldwide?
Absolutely. The Brazilian unit is already a reference when it comes to creativity and innovation. Now, we are in the limelight. Such initiative just showed that it is possible to promote medicine in the pharmaceutical industry.
|
Print this page
Mail this page